Loading...
Entheon Biomedical Corp.
ENBI.CN•CNQ
Healthcare
Biotechnology
CA$0.10
CA$-0.01(-12.50%)
Entheon Biomedical Corp. (ENBI.CN) Financial Performance & Income Statement Overview
Review Entheon Biomedical Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-100.00%
↓ 100.00%
Operating Income Growth
-5.95%
↓ 5.95%
Net Income Growth
-5.97%
↓ 5.97%
Operating Cash Flow Growth
1.19%
↑ 1.19%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-133.11%
↓ 133.11%
ROIC
-64.46%
↓ 64.46%
Entheon Biomedical Corp. (ENBI.CN) Income Statement & Financial Overview
Review Entheon Biomedical Corp.'s (ENBI.CN) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $149199.00 | $85389.00 | $67278.00 | $102069.00 |
| Operating Expenses | $149199.00 | $85389.00 | $67278.00 | $102069.00 |
| Total Costs & Expenses | $149199.00 | $85389.00 | $67278.00 | $102069.00 |
| Interest Income | $3591.00 | $0.00 | $0.00 | $7506.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $2580.00 | $102069.00 |
| EBITDA | -$149000.00 | -$85389.00 | -$64698.00 | $7506.00 |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$153000.00 | $0.00 | -$67278.00 | -$102000.00 |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | $3591.00 | -$83800.00 | $2575.00 | $7506.00 |
| Income Before Tax | -$146000.00 | -$83800.00 | -$64703.00 | -$94563.00 |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$102000.00 |
| Net Income | -$146000.00 | -$83800.00 | -$64703.00 | -$94563.00 |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | -$0.01 | -$0.009 | -$0.007 | -$0.01 |
| Diluted EPS | -$0.01 | -$0.009 | -$0.007 | -$0.01 |
| Weighted Avg Shares Outstanding | $12.03M | $8.86M | $8.86M | $7.32M |
| Weighted Avg Shares Outstanding (Diluted) | $12.03M | $8.86M | $8.86M | $7.32M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan